Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-010367
Filing Date
2025-03-14
Accepted
2025-03-14 16:10:46
Documents
70
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1375504
2 ex4-13.htm EX-4.13 45648
3 ex10-14.htm EX-10.14 102207
4 ex10-15.htm EX-10.15 52169
5 ex14-1.htm EX-14.1 107612
6 ex19-1.htm EX-19.1 219904
7 ex23-1.htm EX-23.1 3263
8 ex31-1.htm EX-31.1 14630
9 ex31-2.htm EX-31.2 14602
10 ex32-1.htm EX-32.1 7162
11 ex97-1.htm EX-97.1 26455
12 image_001.jpg GRAPHIC 98523
13 image_002.jpg GRAPHIC 44427
14 image_003.jpg GRAPHIC 38244
15 image_004.jpg GRAPHIC 36180
  Complete submission text file 0001493152-25-010367.txt   7058947

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE bfrg-20241231.xsd EX-101.SCH 42462
17 XBRL CALCULATION FILE bfrg-20241231_cal.xml EX-101.CAL 48069
18 XBRL DEFINITION FILE bfrg-20241231_def.xml EX-101.DEF 175828
19 XBRL LABEL FILE bfrg-20241231_lab.xml EX-101.LAB 433378
20 XBRL PRESENTATION FILE bfrg-20241231_pre.xml EX-101.PRE 308396
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 709100
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41600 | Film No.: 25740097
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)